Annual CFF
-$105.55 M
-$112.39 M-1642.93%
December 31, 2023
Summary
- As of February 7, 2025, HRMY annual cash flow from financing activities is -$105.55 million, with the most recent change of -$112.39 million (-1642.93%) on December 31, 2023.
- During the last 3 years, HRMY annual CFF has fallen by -$314.71 million (-150.46%).
- HRMY annual CFF is now -150.46% below its all-time high of $209.16 million, reached on December 31, 2020.
Performance
HRMY Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$1.18 M
+$2.27 M+65.90%
September 30, 2024
Summary
- As of February 7, 2025, HRMY quarterly cash flow from financing activities is -$1.18 million, with the most recent change of +$2.27 million (+65.90%) on September 30, 2024.
- Over the past year, HRMY quarterly CFF has increased by +$52.35 million (+97.80%).
- HRMY quarterly CFF is now -100.86% below its all-time high of $136.62 million, reached on September 30, 2020.
Performance
HRMY Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$61.78 M
+$53.92 M+46.61%
September 30, 2024
Summary
- As of February 7, 2025, HRMY TTM cash flow from financing activities is -$61.78 million, with the most recent change of +$53.92 million (+46.61%) on September 30, 2024.
- Over the past year, HRMY TTM CFF has increased by +$43.77 million (+41.47%).
- HRMY TTM CFF is now -126.34% below its all-time high of $234.53 million, reached on September 30, 2020.
Performance
HRMY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
HRMY Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1642.9% | +97.8% | +41.5% |
| 3 y3 years | -150.5% | -275.4% | -7536.3% |
| 5 y5 years | -588.3% | -102.4% | -143.0% |
HRMY Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1522.7% | at low | -116.6% | +97.9% | -648.9% | +46.6% |
| 5 y | 5-year | -150.5% | at low | -100.9% | +97.9% | -126.3% | +46.6% |
| alltime | all time | -150.5% | at low | -100.9% | +97.9% | -126.3% | +46.6% |
Harmony Biosciences Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.18 M(-65.9%) | -$61.78 M(-46.6%) |
| Jun 2024 | - | -$3.45 M(-5.2%) | -$115.70 M(+2.8%) |
| Mar 2024 | - | -$3.63 M(-93.2%) | -$112.59 M(+6.7%) |
| Dec 2023 | -$105.55 M(-1642.9%) | -$53.52 M(-2.9%) | -$105.55 M(+113.8%) |
| Sep 2023 | - | -$55.10 M(>+9900.0%) | -$49.37 M(-734.8%) |
| Jun 2023 | - | -$339.00 K(-109.9%) | $7.78 M(-12.3%) |
| Mar 2023 | - | $3.41 M(+28.3%) | $8.87 M(+29.6%) |
| Dec 2022 | $6.84 M(-7.8%) | $2.66 M(+29.7%) | $6.84 M(-39.2%) |
| Sep 2022 | - | $2.05 M(+173.3%) | $11.26 M(+26.6%) |
| Jun 2022 | - | $750.00 K(-45.8%) | $8.89 M(+1.2%) |
| Mar 2022 | - | $1.38 M(-80.4%) | $8.79 M(+18.5%) |
| Dec 2021 | $7.42 M | $7.07 M(-2359.4%) | $7.42 M(-1017.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$313.00 K(-148.3%) | -$809.00 K(-100.6%) |
| Jun 2021 | - | $648.00 K(+5300.0%) | $136.13 M(+0.5%) |
| Mar 2021 | - | $12.00 K(-101.0%) | $135.41 M(-35.3%) |
| Dec 2020 | $209.16 M(+45.5%) | -$1.16 M(-100.8%) | $209.16 M(-10.8%) |
| Sep 2020 | - | $136.62 M(<-9900.0%) | $234.53 M(+59.8%) |
| Jun 2020 | - | -$67.00 K(-100.1%) | $146.77 M(-26.4%) |
| Mar 2020 | - | $73.76 M(+204.7%) | $199.31 M(+38.6%) |
| Dec 2019 | $143.77 M(+565.1%) | $24.21 M(-50.5%) | $143.77 M(+20.2%) |
| Sep 2019 | - | $48.87 M(-6.9%) | $119.56 M(+69.1%) |
| Jun 2019 | - | $52.48 M(+188.1%) | $70.69 M(+288.1%) |
| Mar 2019 | - | $18.22 M | $18.22 M |
| Dec 2018 | $21.61 M | - | - |
FAQ
- What is Harmony Biosciences Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual CFF year-on-year change?
- What is Harmony Biosciences Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly CFF year-on-year change?
- What is Harmony Biosciences Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings TTM CFF year-on-year change?
What is Harmony Biosciences Holdings annual cash flow from financing activities?
The current annual CFF of HRMY is -$105.55 M
What is the all time high annual CFF for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual cash flow from financing activities is $209.16 M
What is Harmony Biosciences Holdings annual CFF year-on-year change?
Over the past year, HRMY annual cash flow from financing activities has changed by -$112.39 M (-1642.93%)
What is Harmony Biosciences Holdings quarterly cash flow from financing activities?
The current quarterly CFF of HRMY is -$1.18 M
What is the all time high quarterly CFF for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly cash flow from financing activities is $136.62 M
What is Harmony Biosciences Holdings quarterly CFF year-on-year change?
Over the past year, HRMY quarterly cash flow from financing activities has changed by +$52.35 M (+97.80%)
What is Harmony Biosciences Holdings TTM cash flow from financing activities?
The current TTM CFF of HRMY is -$61.78 M
What is the all time high TTM CFF for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high TTM cash flow from financing activities is $234.53 M
What is Harmony Biosciences Holdings TTM CFF year-on-year change?
Over the past year, HRMY TTM cash flow from financing activities has changed by +$43.77 M (+41.47%)